Lundbeckfonden BioCapital

Lundbeckfonden BioCapital

Copenhagen, Capital Region of Denmarklundbeckfonden.com

Overview

Lundbeckfonden BioCapital is the venture capital arm of the Lundbeck Foundation. It operates as an evergreen fund that invests in life science companies, primarily those based in Denmark, to support the translation and commercialization of new scientific research. It was formed by combining the foundation's previous investment units, Lundbeckfonden Ventures and Lundbeckfonden Emerge. The fund invests across all therapeutic areas and stages of development. Lundbeckfonden Emerge, its predecessor, was the foundation's early-stage, evergreen investment unit focused on building and financing biotech companies based on Danish research.

Portfolio Companies

9

Investments

CompanyDateStageLead
SNIPR BiomeAug 2025Series BLead
EnteromeJun 2025VC RoundCo-investor
KvantifyJul 2024SeedCo-investor
NMD PharmaNov 2023Series B ExtensionCo-investor
Notify TherapeuticsSep 2023SeedLead

Key People

Kevin Dolowy Dalgaard

Senior Principal

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersCopenhagen, Capital Region of Denmark
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.